Workflow
多元融资
icon
Search documents
华恒生物(688639.SH):拟筹划H股上市
Ge Long Hui A P P· 2025-07-30 10:27
Core Viewpoint - The company is planning to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange to enhance its global development strategy, brand influence, and core competitiveness while optimizing its capital structure and broadening financing channels [1] Group 1 - The company aims to deepen its global development strategy and strengthen its industry-leading position [1] - The issuance of H-shares is part of the company's efforts to leverage international capital market resources and mechanisms [1] - The company is currently discussing specific details of the H-share listing with relevant intermediaries, and no changes to the controlling shareholder or actual controller will occur as a result of this listing [1]
华恒生物:正在筹划发行境外股份(H股)并在香港联交所上市
news flash· 2025-07-30 10:22
Core Viewpoint - The company is planning to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange to advance its global development strategy and enhance brand influence and core competitiveness [1] Group 1 - The initiative aims to optimize the capital structure and broaden diversified financing channels [1] - The company seeks to comprehensively improve governance levels and overall strength [1] - Details regarding the H-share listing are not yet determined, and it will not lead to changes in the controlling shareholder or actual controller [1]